Trials / Completed
CompletedNCT02434653
A Comparison Between Two Strategies for Postpartum Anemia Diagnosis and Follow up After Vaginal Deliveries
A Comparison Between Two Strategies for Postpartum Anemia Diagnosis and Follow up After Vaginal Deliveries - Hemoglobin Screening in High Risk Population Versus by Symptoms
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 1,679 (actual)
- Sponsor
- HaEmek Medical Center, Israel · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Anemia diagnosis by hemoglobin level monitoring in women after vaginal delivery by symptoms versus screening of women at increased risk for post-partum anemia.
Detailed description
Anemia is common following delivery. It is associated with some serious complications including increased risk for syncope and in severe cases even cardiogenic shock. Yet, anemia-associated symptoms might manifest relatively late after the patient have lost a fair amount of blood, which was not diagnosed early enough. To date, there are not acceptable guidelines for monitoring hemoglobin levels after delivery. Theoretically, there are 2 approaches for hemoglobin monitoring - one by taking hemoglobin levels in order to diagnose anemia in patients reporting anemia-associated symptoms. The other approach is by screening of women at increased risk for post-partum anemia. In the present study we aimed to compare those 2 approaches.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Monitoring hemoglobin levels following anemia associated symptoms | Post-partum anemia will be diagnosed after vaginal delivery by taking hemoglobin levels to patients with symptoms consistent with anemia, severe postpartum hemorrhage or hemoglobin level below 8 g/dL. |
| OTHER | Monitoring hemoglobin levels to detect anemia by screening of women at increased risk for post partum anemia | Post-partum anemia will be diagnosed after vaginal delivery by taking hemoglobin levels to high risk women for post-partum anemia, defined as hemoglobin levels of 10.5 g/dl or below around delivery, or severe postpartum hemorrhage with or without symptoms associated with anemia |
Timeline
- Start date
- 2015-06-01
- Primary completion
- 2017-05-01
- Completion
- 2017-05-01
- First posted
- 2015-05-05
- Last updated
- 2017-07-14
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT02434653. Inclusion in this directory is not an endorsement.